In short
China's 2024 hypertension guideline keeps the 140/90 mmHg diagnosis threshold and a below-130/80 mmHg treatment target when tolerated. It adds grading/staging/phenotyping, lifestyle and device-based therapies, and broader comorbidity coverage.
What this guide covers: What is hypertension? · Key updates in the 2024 edition · Lifestyle and diet · Treatment options · Why it matters for international patients
What is hypertension?
High blood pressure (hypertension) is a long-term condition in which the force of blood against artery walls stays consistently too high. China's 2024 guideline keeps the diagnostic threshold at 140/90 mmHg, with a treatment target of below 130/80 mmHg when tolerated.
Key updates in the 2024 edition
The 2024 revision is the 5th edition of China's national guideline. It introduces a new framework of "grading, staging, and phenotyping," adds chapters on hypertension prevention programs, internet-based care, and reversal of target-organ damage, and expands coverage of special populations and comorbidities (e.g., obesity, COPD, cancer therapy, autoimmune disease).
Lifestyle and diet
Treatment begins with therapeutic lifestyle changes grounded in Chinese evidence: reduce salt intake (replace with salt substitutes where appropriate), adopt a healthy diet, maintain healthy sleep, and manage weight. Large Chinese trials (SSaSS, DECIDE-Salt, CHH) support these measures.
Treatment options
Beyond standard drugs, the guideline endorses newer approaches such as ARNI, MRA, endothelin dual-receptor antagonists, SGLT2 inhibitors / GLP-1 receptor agonists, traditional Chinese medicine, renal denervation (RDN), and device-based therapies. Blood pressure, heart rate, and uric acid are all actively managed.
Why it matters for international patients
If you are managing hypertension while in China, ask your physician about the 130/80 target and whether salt-substitute or device-based options suit you. Reliable care is widely available at tertiary hospitals.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.


